English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

indol/obesity

The link is saved to the clipboard
ArticlesClinical trialsPatents
10 results

3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to a series of 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine derivatives, pharmaceutical compositions containing them and intermediates used in their preparation. The compounds of the invention are ligands for the neuropeptide Y Y5 (NPY5) receptor, a

3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION This invention relates to a series of 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine derivatives, pharmaceutical compositions containing them and intermediates used in their preparation. The compounds of the invention are ligands for the neuropeptide Y Y5 (NPY5) receptor, a

Crystalline hydrochloride salt of (1-(4-fluorophenyl)-1H-indol-5-yl)-(3-(4-(thiazole-2-carbonyl)piperazin-1- -yl)azetidin-1-yl)methanone

Only registered users can translate articles
Log In/Sign up
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT The research and development of the invention described below was not federally sponsored. FIELD OF THE INVENTION The present invention relates to a crystalline hydrochloride salt of

Anti-obesity agents

Only registered users can translate articles
Log In/Sign up
This invention relates to anti-obesity agents and their use in preventing or treating obesity in mammals, particularly humans. Hitherto the usual method employed to treat obesity in man has been to reduce the intake of food either by a low calorie diet or by the use of appetite suppressant

3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use

Only registered users can translate articles
Log In/Sign up
FIELD OF INVENTION The present invention relates to novel 3-(indol-3-yl)-pyridine derivatives, including pharmaceutically acceptable enantiomers, salts and solvates thereof. Compounds of the invention are inhibitors of TDO2 (tryptophan 2,3-dioxygenase) and are useful as therapeutic compounds,

4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use

Only registered users can translate articles
Log In/Sign up
BACKGROUND 1. Technical Field of Invention The present invention embodiments relate to novel 4-(indol-3-yl)-pyrazole derivatives, including pharmaceutically acceptable enantiomers, salts and solvates thereof. Compounds of certain embodiments of the invention are inhibitors of TDO2 (tryptophan

Indol derivatives, the method for preparing thereof and composition for the prevention and treatment of metabolic disorder containing the same as an active ingredient

Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Stage of International Application No. PCT/KR2007/004722, filed Sep. 27, 2007, which claims the benefit of Korean Patent Application KR10-2006-0094138, filed Sep. 27, 2006, both of which are hereby incorporated by

3-indol substituted derivatives, pharmaceutical compositions and methods for use

Only registered users can translate articles
Log In/Sign up
FIELD OF INVENTION The present invention relates to novel 3-(indol-3-yl)-pyridine derivatives, including pharmaceutically acceptable enantiomers, salts and solvates thereof. Compounds of the invention are inhibitors of TDO2 (tryptophan 2,3-dioxygenase) and are useful as therapeutic compounds,

Indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient

Only registered users can translate articles
Log In/Sign up
CROSS-REFERENCES TO RELATED APPLICATION This patent application claims the benefit of priority under 35 U.S.C. .sctn.119 from Korean Patent Application No. 10-2008-0033284 filed Apr. 10, 2008, the contents of which are incorporated herein by reference. TECHNICAL FIELD The present disclosure relates

Serotonin-like 9-substituted hypoxanthine and methods of use

Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION The present invention is broadly directed to purine based compounds. More particularly, the present invention is directed to a novel purine analog having activity involving the serotonin neurotransmitter system in addition to other physiological activities and to associated
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge